Recent characterisation of Trm in the RA ST by gene expression profiling and surface marker analysis revealed that CD8+ Trm cells (CD69+CD103+) were more prevalent than CD4+ [45]. This evidence concerns the gene CD4 and rheumatoid arthritis.